This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med 2007; 146: 87–95.
Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006; 20: 1645–1654.
Wagner ND, Ambinder RF . Blood and marrow transplant for lymphoma patients with HIV/AIDS. Curr Opin Oncol 2008; 20: 201–205.
Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355–365.
Gupta V, Tomblyn M, Pederson T, Thompson J, Gress J, Storek J et al. Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders. Biol Blood Marrow Transplant 2007; 13: 5–6.
Schlegel P, Beatty P, Halvorsen R, McCune J . Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia. J Acquir Immune Defic Syndr 2000; 24: 289–290.
Tomonari A, Takahashi S, Shimohakamada Y, Ooi J, Takasugi K, Ohno N et al. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia. Bone Marrow Transplant 2005; 36: 261–262.
Wolf T, Rickerts V, Staszewski S, Kriener S, Wassmann B, Bug G et al. First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemia. Haematologica 2007; 92: e56–e58.
Bryant A, Milliken S . Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma. Biol Blood Marrow Transplant 2008; 14: 601–602.
Hutter G, Nowak D, Mossner M, Ganepola S, Musig A, Allers K et al. Long term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N Engl J Med 2009; 360: 692–698.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Polizzotto, M., Skinner, M., Cole-Sinclair, M. et al. Allo-SCT for hematological malignancies in the setting of HIV. Bone Marrow Transplant 45, 584–586 (2010). https://doi.org/10.1038/bmt.2009.168
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.168
This article is cited by
-
Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation
Bone Marrow Transplantation (2016)
-
HIV and Stem Cell Transplantation
Current Infectious Disease Reports (2014)
-
Hematopoietic Stem Cell Transplantation in Patients Infected With HIV
Current HIV/AIDS Reports (2010)